Dexmedetomidine postconditioning attenuates myocardial ischemia/reperfusion injury by activating the Nrf2/Sirt3/SOD2 signaling pathway in the rats

References

• Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association. Circulation. 2022:CIR0000000000001052.
   Google Scholar
• Piao H, Takahashi K, Yamaguchi Y, et al. Transient receptor potential melastatin-4 is involved in hypoxia-reoxygenation injury in the cardiomyocytes. PLoS One. 2015;10(4):e0121703.
   PubMed Web of Science ®Google Scholar
• Hausenloy D, Yellon D. Myocardial ischemia-reperfusion injury: a neglected therapeutic target. J Clin Invest. 2013;123(1):92–100.
   PubMed Web of Science ®Google Scholar
• Ruiz-Meana M, Boengler K, Garcia-Dorado D, et al. Ageing, sex, and cardioprotection. Br J Pharmacol. 2020;177(23):5270–5286.
   PubMed Web of Science ®Google Scholar
• Bulluck H, Hausenloy DJ. Ischaemic conditioning: are we there yet? Heart. 2015;101(13):1067–1077.
   PubMed Web of Science ®Google Scholar
• Chi HJ, Chen ML, Yang XC, et al. Progress in therapies for myocardial ischemia reperfusion injury. Curr Drug Targets. 2017;18(15):1712–1721.
   PubMed Web of Science ®Google Scholar
• Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol Rev. 2008;88(2):581–609.
   PubMed Web of Science ®Google Scholar
• Shen Y, Liu X, Shi J, et al. Involvement of Nrf2 in myocardial ischemia and reperfusion injury. Int J Biol Macromol. 2019;125:496–502.
   PubMed Web of Science ®Google Scholar
• Satterstrom F, Swindell W, Laurent G, et al. Nuclear respiratory factor 2 induces SIRT3 expression. Aging Cell. 2015;14(5):818–825.
   PubMed Web of Science ®Google Scholar
• Zeng H, Wang L, Zhang J, et al. Activated PKB/GSK-3 synergizes with PKC- signaling in attenuating myocardial ischemia/reperfusion injury potentiation of NRF2 activity: therapeutic efficacy of dihydrotanshinone-I. Acta Pharm Sin B. 2021;11(1):71–88.
   PubMed Web of Science ®Google Scholar
• Xu JJ, Cui J, Lin Q, et al. Protection of the enhanced Nrf2 deacetylation and its downstream transcriptional activity by SIRT1 in myocardial ischemia/reperfusion injury. Int J Cardiol. 2021;342:82–93.
   PubMed Web of Science ®Google Scholar
• Liu J, Li D, Zhang T, et al. SIRT3 protects hepatocytes from oxidative injury by enhancing ROS scavenging and mitochondrial integrity. Cell Death Dis. 2017;8(10):e3158.
   PubMed Web of Science ®Google Scholar
• Tao R, Coleman M, Pennington J, et al. Sirt3-mediated deacetylation of evolutionarily conserved lysine 122 regulates MnSOD activity in response to stress. Mol Cell. 2010;40(6):893–904.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Wang X, Shao X, et al. Tert-butylhydroquinone treatment alleviates contrast-induced nephropathy in rats by activating the Nrf2/Sirt3/SOD2 signaling pathway. Oxid Med Cell Longev. 2019;2019:4657651.
   PubMed Web of Science ®Google Scholar
• Oh J, Choi G, Lee H, et al. 17β-Estradiol protects mesenchymal stem cells against high glucose-induced mitochondrial oxidants production via Nrf2/Sirt3/MnSOD signaling. Free Radic Biol Med. 2019;130:328–342.
   PubMed Web of Science ®Google Scholar
• Ramsay M, Luterman D. Dexmedetomidine as a total intravenous anesthetic agent. Anesthesiology. 2004;101(3):787–790.
   PubMed Web of Science ®Google Scholar
• Cai Y, Xu H, Yan J, et al. Molecular targets and mechanism of action of dexmedetomidine in treatment of ischemia/reperfusion injury. Mol Med Rep. 2014;9(5):1542–1550.
   PubMed Web of Science ®Google Scholar
• Wang N, Nie H, Zhang Y, et al. Dexmedetomidine exerts cerebral protective effects against cerebral ischemic injury by promoting the polarization of M2 microglia via the Nrf2/HO-1/NLRP3 pathway. Inflamm Res. 2022;71(1):93–106.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Kong GY, Pei WM, et al. Dexmedetomidine alleviates hepatic injury via the inhibition of oxidative stress and activation of the Nrf2/HO-1 signaling pathway. Eur Cytokine Netw. 2019;30(3):88–97.
   PubMed Web of Science ®Google Scholar
• Wang Z, Yao M, Jiang L, et al. Dexmedetomidine attenuates myocardial ischemia/reperfusion-induced ferroptosis via AMPK/GSK-3β/Nrf2 axis. Biomed Pharmacother. 2022;154:113572.
   PubMed Web of Science ®Google Scholar
• Wu W, Du Z, Wu L. Dexmedetomidine attenuates hypoxia-induced cardiomyocyte injury by promoting telomere/telomerase activity: possible involvement of ERK1/2-Nrf2 signaling pathway. Cell Biol Int. 2022;46(7):1036–1046.
   PubMed Web of Science ®Google Scholar
• Pan S, Chen Y, Zhang X, et al. The JAK2/STAT3 pathway is involved in dexmedetomidine-induced myocardial protection in rats undergoing cardiopulmonary bypass. Ann Transl Med. 2020;8(7):483.
   PubMed Web of Science ®Google Scholar
• Zhang J, Xia F, Zhao H, et al. Dexmedetomidine-induced cardioprotection is mediated by inhibition of high mobility group box-1 and the cholinergic anti-inflammatory pathway in myocardial ischemia-reperfusion injury. PLoS One. 2019;14(7):e0218726.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li Y, Wang Y, et al. Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis. Biosci Rep. 2020;40(5):BSR20194030.
   PubMedGoogle Scholar
• Mimuro S, Katoh T, Suzuki A, et al. Deterioration of myocardial injury due to dexmedetomidine administration after myocardial ischaemia. Resuscitation. 2010;81(12):1714–1717.
   PubMed Web of Science ®Google Scholar
• Tosaka S, Tosaka R, Matsumoto S, et al. Roles of cyclooxygenase 2 in sevoflurane- and olprinone-induced early phase of preconditioning and postconditioning against myocardial infarction in rat hearts. J Cardiovasc Pharmacol Ther. 2011;16(1):72–78.
   PubMed Web of Science ®Google Scholar
• Peng K, Chen W, Xia F, et al. Dexmedetomidine post-treatment attenuates cardiac ischaemia/reperfusion injury by inhibiting apoptosis through HIF-1α signalling. J Cardiovasc Pharmacol. 2020;24(1):850–861.
   Google Scholar
• Sun Q, Wu Y, Zhao F, et al. Maresin 1 ameliorates lung ischemia/reperfusion injury by suppressing oxidative stress via activation of the Nrf-2-mediated HO-1 signaling pathway. Oxid Med Cell Longev. 2017;2017:9634803.
   PubMed Web of Science ®Google Scholar
• Yu P, Zhang J, Yu S, et al. Protective effect of sevoflurane postconditioning against cardiac ischemia/reperfusion injury via ameliorating mitochondrial impairment, oxidative stress and rescuing autophagic clearance. PLoS One. 2015;10(8):e0134666.
   PubMed Web of Science ®Google Scholar
• Yang Y, Yang M, Ai F, et al. Cardioprotective effect of aloe vera biomacromolecules conjugated with selenium trace element on myocardial ischemia-reperfusion injury in rats. Biol Trace Elem Res. 2017;177(2):345–352.
   PubMed Web of Science ®Google Scholar
• Cho H, Kim K, Kwak J, et al. Protective mechanism of anethole on hepatic ischemia/reperfusion injury in mice. J Nat Prod. 2013;76(9):1717–1723.
   PubMed Web of Science ®Google Scholar
• Liu Y, Chu Y, Zhang X, et al. TGFβ1 protects myocardium from apoptosis and oxidative damage after ischemia reperfusion. Eur Rev Med Pharmacol Sci. 2017;21(7):1551–1558.
   PubMed Web of Science ®Google Scholar
• Hausenloy D, Garcia-Dorado D, Bøtker H, et al. Novel targets and future strategies for acute cardioprotection: position paper of the European society of cardiology working group on cellular biology of the heart. Cardiovasc Res. 2017;113(6):564–585.
   PubMed Web of Science ®Google Scholar
• Hausenloy D, Boston-Griffiths E, Yellon D. Cardioprotection during cardiac surgery. Cardiovasc Res. 2012;94(2):253–265.
   PubMed Web of Science ®Google Scholar
• Wu G, Chen J, Tsai H, et al. Protection of dexmedetomidine against ischemia/reperfusion-induced apoptotic insults to neuronal cells occurs via an intrinsic mitochondria-dependent pathway. J Cell Biochem. 2017;118(9):2635–2644.
   PubMed Web of Science ®Google Scholar
• Ibacache M, Sanchez G, Pedrozo Z, et al. Dexmedetomidine preconditioning activates pro-survival kinases and attenuates regional ischemia/reperfusion injury in rat heart. Biochim Biophys Acta. 2012;1822(4):537–545.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wu S, Yu X, et al. Dexmedetomidine protects Rat liver against ischemia-reperfusion injury partly by the α2A-adrenoceptor subtype and the mechanism Is associated with the TLR4/NF-κB pathway. Int J Mol Sci. 2016;17(7):995.
   PubMed Web of Science ®Google Scholar
• Zhang W, Zhang JQ, Meng FM, et al. Dexmedetomidine protects against lung ischemia-reperfusion injury by the PI3K/Akt/HIF-1α signaling pathway. J Anesth. 2016;30(5):826–833.
   PubMed Web of Science ®Google Scholar
• Gu J, Sun P, Zhao H, et al. Dexmedetomidine provides renoprotection against ischemia-reperfusion injury in mice. Crit Care. 2011;15(3):R153.
   PubMed Web of Science ®Google Scholar
• Cao S, Chao D, Zhou H, et al. A novel mechanism for cytoprotection against hypoxic injury: δ-opioid receptor-mediated increase in Nrf2 translocation. Br J Pharmacol. 2015;172(7):1869–1881.
   PubMed Web of Science ®Google Scholar
• Ashrafian H, Czibik G, Bellahcene M, et al. Fumarate is cardioprotective via activation of the Nrf2 antioxidant pathway. Cell Metab. 2012;15(3):361–371.
   PubMed Web of Science ®Google Scholar
• Sun M, Guo M, Ma G, et al. MicroRNA-30c-5p protects against myocardial ischemia/reperfusion injury via regulation of Bach1/Nrf2. Toxicol Appl Pharmacol. 2021;426:115637.
   PubMed Web of Science ®Google Scholar
• Jin L, Galonek H, Israelian K, et al. Biochemical characterization, localization, and tissue distribution of the longer form of mouse SIRT3. Protein Sci. 2009;18(3):514–525.
   PubMed Web of Science ®Google Scholar
• Hebert AS, Dittenhafer-Reed KE, Yu W, et al. Calorie restriction and SIRT3 trigger global reprogramming of the mitochondrial protein acetylome. Mol Cell. 2013;49(1):186–199.
   PubMed Web of Science ®Google Scholar
• Zhai M, Li B, Duan W, et al. Melatonin ameliorates myocardial ischemia reperfusion injury through SIRT3-dependent regulation of oxidative stress and apoptosis. J Pineal Res. 2017;63:e12419.
   Web of Science ®Google Scholar
• Meng QT, Cao C, Wu Y, et al. Ischemic post-conditioning attenuates acute lung injury induced by intestinal ischemia-reperfusion in mice: role of Nrf2. Lab Invest. 2016;96(10):1087–1104.
   PubMed Web of Science ®Google Scholar
• Fei L, Jingyuan X, Fangte L, et al. Preconditioning with rHMGB1 ameliorates lung ischemia-reperfusion injury by inhibiting alveolar macrophage pyroptosis via the Keap1/Nrf2/HO-1 signaling pathway. J Transl Med. 2020;18(1):301.
   PubMed Web of Science ®Google Scholar
• Gu J, Huang H, Liu C, et al. Pinocembrin inhibited cardiomyocyte pyroptosis against doxorubicin-induced cardiac dysfunction via regulating Nrf2/Sirt3 signaling pathway. Int Immunopharmacol. 2021;95:107533.
   PubMed Web of Science ®Google Scholar
• Drenger B, Ostrovsky IA, Barak M, et al. Diabetes blockade of sevoflurane postconditioning is not restored by insulin in the rat heart: phosphorylated signal transducer and activator of transcription 3- and phosphatidylinositol 3-kinase-mediated inhibition. Anesthesiology. 2011;114(6):1364–1372.
   PubMed Web of Science ®Google Scholar
• Gross ER, Hsu AK, Gross GJ. Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3beta. Diabetes. 2007;56(1):127–136.
   PubMed Web of Science ®Google Scholar
• Du J, Xu Z, Zhen J, et al. Dexmedetomidine attenuates myocardial ischemia/reperfusion injury through regulating lactate signaling cascade in mice. Eur Rev Med Pharmacol Sci. 2019;23(8):3527–3532.
   PubMed Web of Science ®Google Scholar
• Cheng XY, Gu XY, Gao Q, et al. Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury. Mol Med Rep. 2016;14(1):797–803.
   PubMed Web of Science ®Google Scholar